This Viewpoint considers whether medical assistance in dying should be included as a tenet of palliative care medicine.
Risultati per: Linee guida sulle cure palliative nei pazienti affetti da cancro
Questo è quello che abbiamo trovato per te
Telehealth vs In-Person Early Palliative Care for Patients With Advanced Lung Cancer
This randomized, multisite, comparative effectiveness trial investigates whether early palliative care delivered via video or in-person visits demonstrated equivalent effects on quality of life for patients with advanced non–small cell lung cancer and their caregivers.
Improving Palliative Care Access for Patients With Cancer
Palliative care is not new. It evolved in the 1960s and 1970s before many other medical specialties, such as medical oncology, emergency medicine, and critical care medicine. Although it would be unimaginable to conceive of hospitals, cancer centers, or universities without these 3 specialties, for palliative care, the road toward recognized specialty and adoption by organized medicine was much more difficult, at least in part because of its origins in community hospices and palliative care teams rather than major academic centers and its focus on care of the person rather than more traditional biomedical issues.
Cure più mirate contro i tumori con la Teranostica, progetto Ue
Coordina l’Università Cattolica, approccio ‘vedo e curo’
IA scova le malattie genetiche osservando le foto dei pazienti
Possono indirizzare lo specialista verso la diagnosi corretta
Percorsi personalizzati contro il cancro legati al gene BRCA
Cancro al seno, l'IA svela chi lo svilupperà dalle mammografie
Accuratezza pari o maggiore dei calcolatori in uso
Tumore del pancreas, intervento mini-invasivo su due pazienti
Prima volta presso l’Azienda Ospedaliero Universitaria Marche
Health professionals and caregivers perspectives on improving paramedics provision of palliative care in Australian communities: a qualitative study
Objectives
Paramedics have the potential to make a substantial contribution to community-based palliative care provision. However, they are hindered by a lack of policy and institutional support, as well as targeted education and training. This study aimed to elicit paramedics’, palliative care doctors’ and nurses’, general practitioners’, residential aged care nurses’ and bereaved families and carers’ attitudes and perspectives on how palliative paramedicine can be improved to better suit the needs of community-based patients, their families and carers, and the clinicians involved in delivering the care.
Design
In this qualitative study underpinned by a social constructivist epistemology, semistructured interviews were conducted.
Setting and participants
50 participants with palliative paramedicine experience, from all jurisdictions of Australia. Participants were interviewed between November 2021 and April 2022.
Results
All participants suggested paramedics play an important adjunct role in the provision of palliative and end-of-life care in home-based settings. Three levels of opportunities for improvement were identified: macrolevel (policy and frameworks; funding and education; accessing medical records and a widening scope); mesolevel (service-level training; interprofessional understanding and communities of practice and community expectations) and microlevel (palliative care subspecialty; debriefing and self-care and partnering with families).
Conclusion
To enhance paramedic capacity to provide palliative care support, improvements targeting systems, services, communities and individuals should be made. This calls for stronger inclusion of paramedicine in interdisciplinary palliative care and greater investment in both the generalist and specialist palliative paramedicine workforce.
Linee guida per la gestione del carcinoma epatocellulare negli adulti
Linee guida sul carcinoma ovarico, tubarico e peritoneale primario
Nuove linee guida per la gestione cardiovascolare nella chirurgia non cardiaca
La regina di Spagna a Milano per la ricerca contro il cancro
Visita all’Istituto di oncologia molecolare di Fondazione Airc
Giornata Nazionale per la Sicurezza delle Cure dell'Oms
Importante momento formativo organizzato dall’Ars in Regione
Melanoma avanzato, il 43% dei pazienti è vivo a 10 anni con la doppia immunoterapia
Con nivolumab più ipilimumab. Dieci anni fa il tasso di sopravvivenza era al 25% dopo un anno
'L'Alzheimer è donna', una guida per familiari e medici
Il geriatra Fantò, ‘è un prototipo di malattia di genere’